Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Clinical Cardiology · 2026-11 · 49 (11)
DOI: 10.1002/clc.70512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 05.11.2026. Verfasst von Wang Jiale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Coronary Restenosis, Stents, Insulin Resistance. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Key Research and Development Program-Research on the integration of traditional Chinese and Western medicine for major and difficult diseases such as….
Abstract (Originalsprache)
Objective
The C‐reactive protein‐triglyceride glucose index (CTI) has been associated with cardiovascular risk. This study evaluated its prognostic value for repeat revascularization and in‐stent restenosis (ISR) in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI).
Methods
A total of 2147 CCS patients undergoing PCI were stratified into CTI tertiles. The primary endpoint was a composite of repeat revascularization and ISR. Kaplan–Meier analysis with log‐rank tests was used to compare event rates. Multivariable Cox proportional hazards models and restricted cubic spline analyses were applied to assess associations. Predictive performance was evaluated using time‐dependent receiver operating characteristic curves.
Results
During a median follow‐up of 60 months, 992 patients (46.2%) experienced the primary endpoint. Event rates increased progressively across CTI tertiles. After multivariable adjustment, CTI remained independently associated with the primary endpoint (HR 1.11; 95% CI 1.01–1.22; p = 0.028). Compared with the lowest tertile, the highest CTI tertile was associated with a 31% higher risk (HR 1.31; 95% CI 1.10−1.55; p = 0.002). A linear dose–response relationship was observed ( p for non‐linearity = 0.172; p overall = 0.040). The multivariable model incorporating CTI showed modest discrimination, with AUCs of 0.627 (95% CI 0.602–0.651) at 3 years and 0.651 (95% CI 0.627–0.674) at 5 years.
Conclusions
CTI is independently associated with increased risks of repeat revascularization and ISR after PCI in patients with CCS. However, its incremental predictive value beyond conventional risk factors appears limited and requires further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Wang Jiale, Liu Longcheng, Ma Lihong
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Key Research and Development Program-Research on the integration of traditional Chinese and Western medicine for major and difficult diseases such as…
Zitieren
APA
Jiale, W., Longcheng, L., Peipei, L., & Lihong, M. (2026). Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Clinical Cardiology, 49(11). https://doi.org/10.1002/clc.70512
Vancouver
Jiale W, Longcheng L, Peipei L, Lihong M. Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Clinical Cardiology. 2026;49(11). doi:10.1002/clc.70512
BibTeX
@article{Jiale2026,
author = {Jiale, Wang and Longcheng, Liu and Peipei, Lu and Lihong, Ma},
title = {Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {11},
doi = {10.1002/clc.70512}
}
EUVIMED